Legis Daily

To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids, and for other purposes.

USA115th CongressHR-6779| House 
| Updated: 9/12/2018
Ken Buck

Ken Buck

Republican Representative

Colorado

Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners. Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 12, 2018
Introduced in House
Sep 12, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • September 12, 2018
    Introduced in House


  • September 12, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Crime and Law Enforcement

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • HR 115-6491: To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids to manufacturers and distributors to help identify, report, and stop suspicious orders of opioids and reduce diversion rates, and for other purposes.
  • S 115-2838: Using Data to Prevent Opioid Diversion Act of 2018
  • S 115-2837: A bill to improve the systems for identifying the diversion of controlled substances.
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale tradesState and local government operations

To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids, and for other purposes.

USA115th CongressHR-6779| House 
| Updated: 9/12/2018
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners. Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 12, 2018
Introduced in House
Sep 12, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • September 12, 2018
    Introduced in House


  • September 12, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ken Buck

Ken Buck

Republican Representative

Colorado

Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • HR 115-6491: To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids to manufacturers and distributors to help identify, report, and stop suspicious orders of opioids and reduce diversion rates, and for other purposes.
  • S 115-2838: Using Data to Prevent Opioid Diversion Act of 2018
  • S 115-2837: A bill to improve the systems for identifying the diversion of controlled substances.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale tradesState and local government operations